Safer Shot Valuation
| SAFS Stock | USD 0.0001 0.00 0.00% |
Safer Shot seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Safer Shot from inspecting the company fundamentals such as Return On Asset of -0.5, total debt of 144.93 K, and Net Income of (87.23 K) as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Safer Shot's price fluctuation is very steady at this time. Calculation of the real value of Safer Shot is based on 3 months time horizon. Increasing Safer Shot's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Safer pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Safer Shot. Since Safer Shot is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Safer Pink Sheet. However, Safer Shot's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Safer Shot's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Safer Shot's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Safer Shot helps investors to forecast how Safer pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Safer Shot more accurately as focusing exclusively on Safer Shot's fundamentals will not take into account other important factors: Safer Shot Total Value Analysis
Safer Shot is at this time forecasted to have valuation of 67.25 K with market capitalization of 3.39 K, debt of 144.93 K, and cash on hands of 71. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Safer Shot fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
67.25 K | 3.39 K | 144.93 K | 71 |
Safer Shot Asset Utilization
One of the ways to look at asset utilization of Safer is to check how much profit was generated for every dollar of assets it reports. Safer Shot has a negative utilization of assets of -0.5 %, losing $0.004996 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Safer Shot shows how discouraging it operates for each dollar spent on its assets.Safer Shot Profitability Analysis
Net Loss for the year was (87.23 K) with profit before overhead, payroll, taxes, and interest of 0.About Safer Shot Valuation
The pink sheet valuation mechanism determines Safer Shot's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Safer Shot based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Safer Shot. We calculate exposure to Safer Shot's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Safer Shot's related companies.Safer Shot, Inc., a development stage company, engages in the development, manufacture, marketing, and sale of non-lethal hand held weapons. Safer Shot, Inc. was founded in 1997 and is headquartered in Annapolis, Maryland. SAFER SHOT is traded on PNK Exchange in the United States.
8 Steps to conduct Safer Shot's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Safer Shot's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Safer Shot's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Safer Shot's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Safer Shot's revenue streams: Identify Safer Shot's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Safer Shot's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Safer Shot's growth potential: Evaluate Safer Shot's management, business model, and growth potential.
- Determine Safer Shot's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Safer Shot's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Safer Pink Sheet Analysis
When running Safer Shot's price analysis, check to measure Safer Shot's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safer Shot is operating at the current time. Most of Safer Shot's value examination focuses on studying past and present price action to predict the probability of Safer Shot's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Safer Shot's price. Additionally, you may evaluate how the addition of Safer Shot to your portfolios can decrease your overall portfolio volatility.